4.6 Review

Hepatitis E Infection in HIV-Infected Patients

期刊

FRONTIERS IN MICROBIOLOGY
卷 10, 期 -, 页码 -

出版社

FRONTIERS MEDIA SA
DOI: 10.3389/fmicb.2019.01425

关键词

HIV; HEV; epidemiology; zoonoses; treatment; prevention; diagnosis

资金

  1. Ministry of Economy and Competitiveness [RD12/0017/0012]
  2. European Regional Development Fund
  3. Health Research Fund from the Institute of Health Carlos III (ISCIII) [PI16/01297]
  4. SPANISH AIDS Research Network [RD16/0025/0034 - ISCIII - FEDER]
  5. Miguel Servet Research Contract by Ministerio de Ciencia, Promocion y Universidades of Spain [CP18/00111]
  6. Sara Borrell Research Contract Program by the Ministerio de Ciencia, Promocion y Universidades of Spain [CD18/00091]

向作者/读者索取更多资源

Background: The hepatitis E virus (HEV) represents a major cause of acute hepatitis worldwide. The majority of HEV cases occur in low-income countries, mainly Asia and Africa, where HEV causes large outbreaks associated with the consumption of contaminated water and high mortality in specific populations. In high-income countries, HEV infection is considered a zoonotic disease that is linked to the consumption of contaminated food. Although a high proportion of cases have self-limiting asymptomatic or subclinical infections, immunosuppression may modify the pathogenesis and clinical impact of this emerging disease. Results and Discussion: Here, we review the current knowledge about the epidemiology, diagnosis, clinical manifestations, management and prevention of HEV infection in HIV-infected subjects. Conclusions: Despite the increasing knowledge about the pathogenesis, epidemiology and clinical impact of HEV infection, several major factors are faced by HIV-infected patients, including treatment recommendations, immunization and risk practices.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据